mortality/aging
| N |
• mice are present at the expected Mendelian ratios at E14.5-P0, indicating normal embryonic survival
|
cardiovascular system
|
• at E14.5 to P0, seven of 22 (32%) embryos exhibit aortic arch artery remodeling defects, including interrupted aortic arch (IAA) type B, hypoplasia of the B segment of the aortic arch, and aberrant retro-esophageal right subclavian artery
|
|
• at E14.5 to P0, seven of 22 (32%) embryos exhibit aberrant retro-esophageal right subclavian artery
|
|
• at E14.5 to P0, seven of 22 (32%) embryos exhibit interrupted aortic arch (IAA) type B
|
|
• at E14.5 to P0, seven of 8 (88%) embryos exhibit outflow tract (OFT) defects, including ventricular septal defect (VSD), double outlet right ventricle, and semilunar valve hyperplasia
• a non-significant trend toward a decrease in proliferating pHH3+ cells and an increase in apoptotic TUNEL+ cells is noted in the OFT at E10.5
|
|
• at E14.5 to P0, seven of 8 (88%) embryos exhibit DORV
|
|
• at E14.5 to P0, seven of 8 (88%) embryos exhibit VSDs
|
|
• at E14.5 to P0, six of 8 (75%) embryos exhibit an aortic valve defect
|
|
• at E14.5 to P0, seven of 8 (88%) embryos exhibit a pulmonary valve defect
|
|
• at PO, pulmonary valve leaflets are enlarged and hyperplastic
|
|
• at E14.5 to P0, seven of 8 (88%) embryos exhibit semilunar valve hyperplasia
• however, atrioventricular (mitral and tricuspid) valves are unaffected
|
embryo
|
• at E14.5 to P0, seven of 22 (32%) embryos exhibit aortic arch artery remodeling defects, including interrupted aortic arch (IAA) type B, hypoplasia of the B segment of the aortic arch, and aberrant retro-esophageal right subclavian artery
|
craniofacial
|
• at E14.5 to P0, seven of 22 (32%) embryos exhibit aortic arch artery remodeling defects, including interrupted aortic arch (IAA) type B, hypoplasia of the B segment of the aortic arch, and aberrant retro-esophageal right subclavian artery
|


Analysis Tools